Research output per year
Research output per year
Research Output
- 15 results
Search results
-
2023
Characterization of Lymph Node Metastases in Prostate Cancer. ASCO, Abst: 380, 01/2023
Gottlieb, J., Hanes, D. A., Hoon, D. S. B. & See all authors in notes, 2023.Research output: Contribution to conference › Abstract
-
Phase 1 clinical update of allogeneic invariant natural killer T cells (iNKTs), agenT-797, alone or in combination with pembrolizumab or nivolumab in patients with advanced solid tumors. #CT275: AACR ProcVol 83; (8_Supplement): CT275. AACR meeting Orlando, FL, 2023.
Carneiro, B., Sanborn, R., Hoon, D. S. B. & See all authors in notes, 2023.Research output: Contribution to conference › Abstract
-
Transcriptomic signatures in melanoma lymph node metastasis that relate to immune oncology treatment. #6375. AACR Proc, Vol 83; AACR meeting Orlando, FL, 2023.
Bustos, M., Hoon, D. S. B. & See all authors in notes, 2023.Research output: Contribution to conference › Abstract
-
UBQLN4 Triggers MRE11a and STING Proteasomal Degradation During Platinum-induced DNA Damage Response in Solid Tumors, Kyoto, Japan , 03/2023.
Hoon, D. S. B., Bustos, M. & See all authors in notes, 2023.Research output: Contribution to conference › Abstract
-
2022
. Immune profiling of metastatic uveal melanoma and response to immune checkpoint inhibitors ASCO, Abst: 9565 Poster: 158, 6/2022
Shao, Y., Hoon, D. S. B. & See all authors in notes, 2022.Research output: Contribution to conference › Abstract
-
Association of interleukin-enhanced factor 2 (ILF2) expression with prognosis and clinico-genomic features in breast cancer (BC). ASCO, Abst: 1030 Poster: 408, 6/2022.
Bustos, M., Hoon, D. S. B. & See all authors in notes, 2022.Research output: Contribution to conference › Abstract
-
HER2 alterations and prognostic implications in all subtypes of breast cancer. ASCO, Abst:1041, 6/2022
O'Keefe, K., Hoon, D. S. B. & See all authors in notes, 2022.Research output: Contribution to conference › Abstract
-
Interleukin enhancer-binding factor 2 amplification controls mRNA stability and enhances DNA damage response in metastatic melanoma AACR Abst# 3233, 6/2022
Zhang, X., Bustos, M., Hoon, D. S. B. & See all authors in notes, 2022.Research output: Contribution to conference › Abstract
-
Molecular characteristics and clinical outcomes of breast cancer with HRAS mutations. ASCO, Abst: 561 Poster: 333, 6/2022.
Kareff, S., Bustos, M., Hoon, D. S. B. & See all authors in notes, 2022.Research output: Contribution to conference › Abstract
-
Multi-Omics and Immune Cell Profiling of Metastatic Uveal Melanomas. AACR, Poster Abst Nr 50. 6/2022
Moser, J., Hoon, D. S. B. & See all authors in notes, 2022.Research output: Contribution to conference › Abstract
-
Pan-cancer association between increased iron utilization and poor prognosis highlights potential of transferrin receptor-targeting therapies in multiple tumor types. ASCO, Abst: 3120 Poster: 112, 6/2022.
Trabolsi, A., Hoon, D. S. B. & See all authors in notes, 2022.Research output: Contribution to conference › Abstract
-
UBQLN4 promotes STING proteasomal degradation during cisplatin-induced DNA damage in triple-negative breast cancer. EMBO Abst, 10/2022
Shoji, Y., Hoon, D. S. B., Bustos, M. & See all authors in notes, 2022.Research output: Contribution to conference › Abstract
-
2021
Diagnostic ability of four cell-free miRNA signatures pre- and post-nephrectomy concordantly found in the tumor and blood from patients with renal cell carcinoma
Bustos, M., Hoon, D. S. B. & See all authors in notes, 2021.Research output: Contribution to conference › Abstract › peer-review
-
Pershing S. Comprehensive characterization of neurotransmitters and neuronal signaling gene alterations in invasive breast cancers has been accepted for Spotlight Poster-Discussion Session presentation. San Antonio Breast Cancer Symp, 2021
Kang, I., Bustos, M., Hoon, D. S. B. & See all authors in notes, 2021.Research output: Contribution to conference › Abstract
-
UBQLN4 regulates cisplatin-resistance in Triple-Negative Breast Cancer by targeting BAT3 for proteasomal degradation. AACR Breast Cancer San Antonio Symp, Abrs Nr P4-01-1, 2021.
Shoji, Y., Hoon, D. S. B., Bustos, M. & See all authors in notes, 2021.Research output: Contribution to conference › Abstract